Posts

Biologics vs. JAK Inhibitors for Atopic Dermatitis: Which One Wins for Your Patient? A 2026 Practical Guide

Staph Aureus on the Skin Associated With Severe Food Allergic Reactions Via a Cascade: IL-33, IL-3, IL-4

Oral ITK Inhibitor Soquelitinib in Development for Atopic Dermatitis

Monoclonal Antibody Targeting OX40L (Amlitelimab) In Development for Atopic Dermatitis

Vtama (Tapinarof): A New Topical Treatment for Atopic Dermatitis as of December 2024

Lebrikizumab (Ebglyss) Approval: A New Treatment Option for Atopic Dermatitis

Blood endotypic signatures in atopic dermatitis

Dupilumab is very effective in difficult‐to‐treat adult atopic dermatitis patients

Dupilumab in real life: much higher frequency of conjunctivitis and eosinophilia reported

Severe Atopic Dermatitis - 2018 WSAAI update

New atopic dermatitis drug approved - Crisaborole (Eucrisa) phosphodiesterase-4 inhibitor, applied topically twice daily

How to use topical steroid - video by National Eczema Association

Atopic Dermatitis In-Depth - Twitter summary from 2014 #ACAAI meeting

October is Eczema Awareness Month - spread the word!

Atopic dermatitis - top articles for July 2014

Dupilumab Injections Improve Atopic Dermatitis

Eczema Awareness Video

Atopic dermatitis associated with food allergy accelerates progression of allergic march

Filaggrin mutations and atopic dermatitis - Twitter summary from 2013 #AAAAI meeting

Atopic dermatitis (eczema) - videos by National Jewish